Tetsunobu Yamane Selected Research

Tetsunobu Yamane Research Topics

2	Infections 01/2022 - 01/2022
2	Sepsis (Septicemia) 01/2022 - 01/2022
2	Atherosclerosis 06/2006 - 07/2004
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Disseminated Intravascular Coagulation 01/2022
1	Propofol Infusion Syndrome 01/2020
1	Acidosis 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020
1	Airway Obstruction (Choking) 09/2016
1	Lymphangioma (Cavernous Lymphangioma) 09/2016
1	Critical Illness (Critically Ill) 08/2015
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2011
1	Body Weight (Weight, Body) 01/2008
1	Hyperemia 01/2008
1	Hypertension (High Blood Pressure) 07/2004

3	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 08/2015
2	LipidsIBA 01/2008 - 07/2004
1	ThrombomodulinIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	AntithrombinsIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Phosphotransferases (Kinase)IBA 01/2020
1	CreatinineIBA 01/2020
1	Propofol (Diprivan)FDA LinkGeneric 01/2020
1	RV 538 (PDMP)IBA 08/2015
1	LipocalinsIBA 01/2011
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2011
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2011
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2008
1	LDL CholesterolIBA 06/2006
1	Aryldialkylphosphatase (Paraoxonase)IBA 06/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2006
1	oxidized low density lipoproteinIBA 07/2004